 | Related Articles |
The development of dendritic cell vaccine-based immunotherapies for glioblastoma.
Semin Immunopathol. 2017 Feb;39(2):225-239
Authors: Reardon DA, Mitchell DA
Abstract
In this review, we focus on the biologic advantages of dendritic cell-based vaccinations as a therapeutic strategy for cancer as well as preclinical and emerging clinical data associated with such approaches for glioblastoma patients.
PMID: 28138787 [PubMed - indexed for MEDLINE]
http://ift.tt/2iuQjc1
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.